GL1X · GenesisL1 explorer

MolNFT v1 · #62694 · protein

Targeted polypharmacology: crystal structure of the C-src kinase domain in complex with PP494, a multitargeted kinase inhibitor

3EN5 · Proto-oncogene tyrosine-protein kinase src: “Targeted polypharmacology: crystal structure of the C-src kinase domain in complex with PP494, a…”. X-ray diffraction, 1 ligand (KS4), 5 pockets (best druggability 0.74). MolNFT v1 #62694…

PDB
3EN5
Type
protein
Length
499 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase src
EC
2.7.10.2
UniProt
P00523
Ligands
KS4
Pockets
5 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein23844% helix, 17% strandP00523
BProto-oncogene tyrosine-protein kinase src (EC 2.7.10.2)protein26143% helix, 16% strandP00523

Ligands and binding sites

  • KS4 · 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18750.740.7886KS4
24150.620.7745empty
33520.590.7630KS4
4530.310.7615empty
5630.290.7414empty

Interfaces

1 interface between chains.

  • A–B · 457 Ų buried · 7 hydrogen bonds · protein-protein

Compared structures

  • 3EN5 · Targeted polypharmacology: crystal structure of the c-Src kinase domain in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.